Literature DB >> 7071913

Incompatible crossmatch following nonreactive antibody detection test. Frequency and cause.

P D Mintz, A L Haines, M F Sullivan.   

Abstract

In order to determine the frequency and cause of an incompatible crossmatch found in specimens for which the antibody detection test was nonreactive, 261, 136 crossmatches performed on 116,278 patient samples from approximately 46,000 different patients were reviewed. One-hundred and one patients were identified whose sera were incompatible in at least one crossmatch following a nonreactive antibody detection test. The cause of the incompatibility was determined in 69 of these. Incompatibility was detected only after 37 degrees C incubation and/or after the antiglobulin phase in 36 (52%). Incompatibility was detected after an immediate-spin and/or incubation at room temperature in 33 (48%). Serologic evaluation did not identify the cause of the incompatibility in 16 of the 101 patients. In eight of these 16 the incompatibility was noted only after 37 degrees C incubation and/or after the antiglobulin phase. Detailed serologic evaluation was not performed on 16 of the 101 patients (all of whose sera were incompatible with only 1 donor unit). In 12 of these 16, the incompatibility was detected only after the antiglobulin phase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071913     DOI: 10.1046/j.1537-2995.1982.22282177114.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Impact of preoperative laboratory investigation and blood cross-match on clinical management of pediatric neurosurgical patients.

Authors:  Michael M H Yang; Ash Singhal; Nicholas Au; A Ross Hengel
Journal:  Childs Nerv Syst       Date:  2015-02-19       Impact factor: 1.475

2.  Type and screen method and Coombs crossmatch method for pretransfusion testing: A prospective comparative study in a tertiary care hospital in Delhi.

Authors:  K Devi Anu; Sangeeta Pahuja; Geetika Sharma
Journal:  Asian J Transfus Sci       Date:  2022-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.